188
Participants
Start Date
November 14, 2023
Primary Completion Date
November 4, 2024
Study Completion Date
July 25, 2025
Veligrotug (VRDN-001)
Veligrotug (VRDN-001) is a humanized monoclonal antibody directed against the IGF-1 receptor
Placebo
5 IV infusions of placebo
North Shore Private Hospital, Saint Leonards
Charité - Universitätsmedizin Berlin KöR, Berlin
Hospital La Arruzafa, Córdoba
Complexo Hospitalario Universitario de Santiago-Hospital Médico-Cirúrxico de Conxo, A Coruña
Department of Ophthalmology, University of Pennsylvania, Philadelphia
Wills Eye Hospital, Philadelphia
Hospital Universitario Ramón y Cajal, Madrid
CHU de Bordeaux - Hôpital Saint-André, Bordeaux
Bascom Palmer Eye Institute - Ophthalmology - Miami, Miami
Sarasota Retina Institute, Sarasota
Marmara University Faculty of Medicine, Istanbul
Universitätsmedizin Göttingen, Göttingen
Hospital Universitario Virgen De La Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
Centre Hospitalier Universitaire De Nantes - G. R. Laennec, Nantes
Universitätsklinikum Essen AöR, Essen
Hospital Universitario Y Politécnico La Fe, Valencia
Kahana Oculoplastic and Orbital Surgery, Livonia
Michigan State University, Department of Neurology, East Lansing
CHU Angers, Angers
Hospital Unviersitario Miguel Servet, Zaragoza
Family Eye Physicians, Ltd, Oak Lawn
Northwestern University, Chicago
Washington University School of Medicine in St Louis - Ophthalmology, St Louis
Baylor College of Medicine (BCM) - Ophthalmology, Houston
Neuro Eye Clinical Trials, Houston
University Medical Center Freiburg, Freiburg im Breisgau
Steven Leibowitz, MD., Las Vegas
Advancing Research International, LLC, Los Angeles
USC Roski Eye Institute, Los Angeles
Cockerham Eye Consultants, PC, San Diego
Amy Patel Jain, MD, Newport Beach
Stanford Byers Eye Institute, Palo Alto
Harborview Medical Center, Seattle
Massachusetts Eye and Ear, Boston
Ophthalmic Consultants of Boston, Boston
Rutgers - New Jersey Medical School, Newark
The Center for Eye and Facial Plastic Surgery, Somerset
University of Vermont Medical Center, Burlington
CH Nice, Nice
Budapest Retina Intezet, Budapest
Ganglion Orvosi Kozpont, Pécs
Pecsi Tudomanyegyetem Klinikai Kozpont Szemeszeti Klinika, Pécs
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok
Oculomedica Sp. z o.o., Bialystok
Optimum Profesorskie Centrum Okulistyki Sp. z o.o., Gdansk
Centrum Medyczne Pulawska Sp. z o.o., Piaseczno
Centrum Medyczne Piasta 47 sp. z o.o., Wałbrzych
Centro de Oftalmologia Barraquer (Barraquer Ophthalmology Centre), Barcelona
Hacettepe Universitesi Tip Fakultesi, Ankara
Gazi University Medical Faculty Hospital, Ankara
Akdeniz University Medical Faculty Hospital, Antalya
Moorfield's Eye Hospital, London
Imperial College Healthcare NHS Trust - Western eye Hospital, London
Guy's and St. Thomas NHS Trust, London
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle
University Hospital Southampton NHS Foundation Trust, Southampton
Viridian Therapeutics, Inc.
INDUSTRY